# The Role of the P2Y12 Receptor in Tissue Factor Induced Coagulation

> **NCT01099566** · PHASE4 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 20 (actual)

## Conditions studied

- Healthy Volunteers
- Sepsis

## Interventions

- **DRUG:** Prasugrel
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01099566
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-10
- **Final completion:** 2010-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2011-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01099566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01099566, "The Role of the P2Y12 Receptor in Tissue Factor Induced Coagulation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01099566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*